Related Experiment Videos
A new class of antigen-specific killer cells
1Department of Cancer Biology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157, USA.
Nature Biotechnology
|January 1, 1997
Summary
Researchers engineered novel antigen-specific killer cells that target and eliminate human immunodeficiency virus (HIV)-infected cells. This breakthrough combines antibody specificity with potent toxins for effective viral therapy.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Current treatments for viral infections like HIV often face challenges with specificity and resistance.
- There is a need for innovative therapeutic strategies that can precisely target infected cells while sparing healthy ones.
Purpose of the Study:
- To design and validate a new class of antigen-specific killer cells.
- To demonstrate the feasibility of creating killer cells that produce and secrete targeted antibody-toxin molecules.
- To evaluate the efficacy of these engineered cells against human immunodeficiency virus (HIV)-1-infected cells.
Main Methods:
- Genetic modification of lymphocytes to produce and secrete targeted antibody-toxin molecules.
- Co-culture of engineered cells with HIV-1-infected cells and uninfected cells.
- Assessment of cell viability and cytotoxic activity against target cells.
Main Results:
- Transduced lymphocytes successfully produced and secreted targeted toxin proteins.
- Engineered killer cells exhibited selective and potent cytotoxicity towards HIV-1-infected cells.
- Transduced cells remained viable, indicating no self-targeting due to the absence of the target antigen on their surface.
Conclusions:
- A novel class of potent, antigen-specific killer cells was successfully generated by combining antibody specificity, toxin potency, and T-cell effector functions.
- This approach offers a promising strategy for the targeted treatment of viral infections, including HIV-1.
- The study demonstrates the potential for genetically modified mammalian cells to produce targeted toxins for in vivo destruction of diseased cells.